Results
|
66821.
|
|
|
66822.
|
|
|
66823.
|
|
|
66824.
|
|
|
66825.
|
|
|
66826.
|
|
|
66827.
|
|
|
66828.
|
|
|
66829.
|
|
|
66830.
|
Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group. [electronic resource] by
- Lück, Hans-Joachim
- Du Bois, Andreas
- Loibl, Sibylle
- Schrader, Iris
- Huober, Jens
- Heilmann, Volker
- Beckmann, Matthias
- Stähler, Ann
- Jackisch, Christian
- Hubalek, Michael
- Richter, Barbara
- Stickeler, Elmar
- Eidtmann, Holger
- Thomssen, Christoph
- Untch, Michael
- Wollschläger, Kerstin
- Schuster, Tibor
- von Minckwitz, Gunter
Producer: 20140127
In:
Breast cancer research and treatment vol. 139
Availability: No items available.
|
|
66831.
|
|
|
66832.
|
|
|
66833.
|
|
|
66834.
|
|
|
66835.
|
|
|
66836.
|
|
|
66837.
|
|
|
66838.
|
|
|
66839.
|
|
|
66840.
|
|